Boost kidney health with these 7 detoxifying foods

Detoxifying your kidneys is important for overall health. Here are seven foods that are particularly beneficial for kidney health:

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dQBwhRk
via IFTTT

Read More

India eases drug approval process, waives local trials for advanced therapies

In a major policy shift, the Indian government has waived local clinical trial requirements for drugs and vaccines approved by major international regulators (US, UK, Japan, Australia, Canada, EU). This move, aimed at expediting access to advanced therapies like CAR T-cell therapy and Sacituzumab govitecan, still ensures post-marketing surveillance by the CDSCO.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/jrOfeKl
via IFTTT

Read More

Biotech giant Amgen plans to open to technology & innovation centre in Hyderabad

US biotech giant Amgen announced plans to open a new technology and innovation site in Hyderabad, India. The site will be located in HITEC City and will occupy six floors of the RMZ Spire Tower. It is expected to be operational in Q4 2024 and has the potential to accommodate up to 3,000 people.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dRoODCN
via IFTTT

Read More

Fortis Healthcare to buy out PE funds from diagnostics arm Agilus

Fortis Healthcare has acquired a 34% stake in Agilus Diagnostics from private equity firms Jacob Ballas and IFC. This transaction valued Agilus at around ₹5,000 crore and increased Fortis's holding from 57% to 91%. Agilus operates 413 laboratories and faced expansion challenges due to investors' reluctance and rising competition from new-age online players.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/z95ukRJ
via IFTTT

Read More

Bajaj could make a difference in healthcare space

The Bajaj group's move into the hospital industry promises to influence the Indian healthcare sector. Private hospitals have shown growth and investor interest has risen post-pandemic. Bajaj plans to establish hospitals in metropolitan areas but will face significant hurdles such as high costs and a lack of medical professionals.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5XqVdFj
via IFTTT

Read More

India waives clinical trial requirement for drugs approved in developed markets

India has waived clinical trial requirements for new drugs with significant therapeutic advances that have been approved in the US, UK, Japan, Australia, Canada, or the EU. The Central Drugs Standard Control Organisation (CDSCO) stated that this move aims to speed up drug availability, especially for rare diseases, pandemics, and special defence needs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gDf06rm
via IFTTT

Read More

India's Fortis Healthcare chairman Ravi Rajagopal resigns

Ravi Rajagopal has resigned as chairman of Fortis Healthcare, effective Sept. 30, due to increased commitments in the U.K. and other regions. He will also step down from the Corporate Social Responsibility Committee. Rajagopal became chairman in June 2018 when Fortis was dealing with significant challenges, and he found his tenure personally fulfilling.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Yp5NGrI
via IFTTT

Read More